Otto Bekers

Professor

Prof. Otto Bekers studied Pharmacy at the University of Leiden and graduated in 1987 with honour. He recieved his PhD degree in 1991 at the Utrecht University, title of his dissertation was 'Inclusion comlexation of cyclodextrins with some cytostatic drugs'. After this he specialised in Clinical Chemistry at the Leyenburg Hospital (now Haga Hospital) in The Hague.

Since 1997 he is working as a Clinical Chemist at the Maastricht UMC+. First as head of the unit General Clinical Chemistry and from 2014 he is professor in Clinical Chemistry and head of the Central Diagnostic Laboratory (CDL).

He is heading the cardiac marker research at the CDL and also focussed on personalised medice.

Central Diagnostic Laboratory
P. Debyelaan 25, 6229 HX Maastricht
PO Box 5800, 6202 AZ Maastricht
Room number: 5.E2.004
T: +31 (0)43 387 646 94

  • 2020
    • Kimenai, D. M., Lindahl, B., Jernberg, T., Bekers, O., Meex, S. J. R., & Eggers, K. M. (2020). Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry. Scientific Reports, 10(1), [15227]. https://doi.org/10.1038/s41598-020-72204-2
    • Martens, R. J. H., Henry, R. M. A., Bekers, O., Dagnelie, P. C., van Dongen, M. C. J. M., Eussen, S. J. P. M., van Greevenbroek, M., Kroon, A. A., Stehouwer, C. D. A., Wesselius, A., Meex, S. J. R., & Kooman, J. P. (2020). Associations of 24-Hour Urinary Sodium and Potassium Excretion with Cardiac Biomarkers: The Maastricht Study. Journal of Nutrition, 150(6), 1413-1424. https://doi.org/10.1093/jn/nxaa080
    • Jessurun, N. T., Wijnen, P. A., Bast, A., van Puijenbroek, E. P., Bekers, O., & Drent, M. (2020). Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers. International journal of molecular sciences, 21(8), [2770]. https://doi.org/10.3390/ijms21082770
    • van Doorn, W. P. T. M., Vroemen, W. H. M., Smulders, M. W., van Suijlen, J. D., van Cauteren, Y. J. M., Bekkers, S. C. A. M., Bekers, O., & Meex, S. J. R. (2020). High-Sensitivity Cardiac Troponin I and T Kinetics after Non-ST-Segment Elevation Myocardial Infarction. Journal of Applied Laboratory Medicine, 5(1), 239-241. https://doi.org/10.1373/jalm.2019.029785
    • Hendrix, M. L. E., Bons, J. A. P., van Haren, A., van Kuijk, S. M. J., van Doorn, W. P. T. M., Kimenai, D. M., Bekers, O., Spaanderman, M. E. A., & Al-Nasiry, S. (2020). Role of sFlt-1 and PlGF in the screening of small-for-gestational age neonates during pregnancy: A systematic review. Annals of Clinical Biochemistry, 57(1), 44-58. [0004563219882042]. https://doi.org/10.1177/0004563219882042
    • Tas, J., van Gassel, R. J. J., Heines, S. J. H., Mulder, M. M. G., Heijnen, N. F. L., Acampo-de Jong, M. J., Bels, J. L. M., Bennis, F. C., Koelmann, M., Groven, R. V. M., Donkers, M. A., van Rosmalen, F., Hermans, B. J. M., Meex, S. J. R., Mingels, A., Bekers, O., Savelkoul, P., Oude Lashof, A. M. L., Wildberger, J., ... van Bussel, B. C. T. (2020). Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht). BMJ Open, 10(9), [040175]. https://doi.org/10.1136/bmjopen-2020-040175
  • 2019
    • Vroemen, W. H. M., van Doorn, W. P. T. M., Kimenai, D. M., Wodzig, W. K. W. H., de Boer, D., Bekers, O., & Meex, S. J. R. (2019). Biotin interference in high-sensitivity cardiac troponin T testing: a real-world evaluation in acute cardiac care. Cardiovascular Research, 115(14), 1950-1951. https://doi.org/10.1093/cvr/cvz277
    • Hendrix, M. L. E., Palm, K. C. M., Van Kuijk, S. M. J., Bekers, O., Spaanderman, M. E. A., Bons, J. A. P., & Al-Nasiry, S. (2019). Longitudinal changes in placental biomarkers in women with early versus late placental dysfunction. Hypertension in Pregnancy, 38(4), 268-277. https://doi.org/10.1080/10641955.2019.1668948
    • Hendrix, M. L. E., Bons, J. A. P., Snellings, R. R. G., Bekers, O., van Kuijk, S. M. J., Spaanderman, M. E. A., & Al-Nasiry, S. (2019). Can Fetal Growth Velocity and First Trimester Maternal Biomarkers Improve the Prediction of Small-for-Gestational Age and Adverse Neonatal Outcome?Fetal Diagnosis and Therapy, 46(4), 274-284. https://doi.org/10.1159/000499580
    • Jessurun, N. T., Drent, M., van Puijenbroek, E. P., Bekers, O., Wijnen, P. A., & Bast, A. (2019). Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects. Current Opinion in Pulmonary Medicine, 25(5), 468-477. https://doi.org/10.1097/MCP.0000000000000590